FindTrial
Sign In

OCCURRENCE OF METABOLIC SYNDROME IN TYPE II DIABETES MELLITUS PATIENTS

A STUDY ON ASSESSMENT OF METABOLIC SYNDROME IN TYPE II DIABETES MELLITUS PATIENTS - AMSIDM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/09/021398
Enrollment
350
Registered
2019-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Control Intervention1: NIL: NIL

Sponsors

MERLIT JAMES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients on diabetic treatment

Exclusion criteria

Exclusion criteria: Type I Diabetes Mellitus. Seriously ill patients, who were under ventilation support and in altered mental status. Patients not giving consent. Pregnant women.

Design outcomes

Primary

MeasureTime frame
occurrence of metabolic syndrome among patients with type II DMTimepoint: 8 months—

Secondary

MeasureTime frame
gender related difference in risk factors among patients with type II DMTimepoint: 8 months—

Countries

India

Contacts

Public ContactMERLIT JAMES

NGSMIPS

treesapv510@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026